GNS, Amgen to use AI to explore patient response to mCRC drug Vectibix

By Shannon Lehnbeuter | Sep 14, 2018 | 3:18 PM GMT

GNS Healthcare Inc. (Cambridge, Mass), Amgen Inc. (NASDAQ:AMGN) and the Alliance for Clinical Trials in Oncology